Jubilant Pharmova Limited(IN:JUBLPHARMA)
₹934.15-19.65 (-2.06%)
IN:JUBLPHARMA
Jubilant Pharmova Limited financials statements
₹934.15
At close:-19.65 (-2.06%)
Want to see IN:JUBLPHARMA full AI Analyst Report?
Jubilant Pharmova Limited (JUBLPHARMA) Financial Statements
2 Followers
Jubilant Pharmova Limited Financial Overview
Jubilant Pharmova Limited's market cap is currently ₹148.79B. The company's EPS TTM is ₹22.24; its P/E ratio is 56.17; and it has a dividend yield of 0.53%. Jubilant Pharmova Limited is estimated to report earnings on February 5, 2027, and the estimated EPS forecast is ₹10.50. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ₹ 82.80B | ₹ 72.34B | ₹ 67.03B | ₹ 62.82B | ₹ 61.30B |
| Gross Profit | ₹ 24.94B | ₹ 46.99B | ₹ 43.52B | ₹ 42.00B | ₹ 46.42B |
| Operating Income | ₹ 8.19B | ₹ 23.56B | ₹ 20.64B | ₹ 19.85B | ₹ 25.68B |
| EBITDA | ₹ 12.66B | ₹ 11.72B | ₹ 9.05B | ₹ 9.29B | ₹ 12.22B |
| Net Income | ₹ 3.98B | ₹ 8.39B | ₹ 771.00M | ₹ -610.00M | ₹ 4.14B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ₹ 12.68B | ₹ 10.89B | ₹ 9.56B | ₹ 10.15B | ₹ 9.86B |
| Total Assets | ₹ 155.23B | ₹ 127.56B | ₹ 115.48B | ₹ 111.57B | ₹ 99.91B |
| Total Debt | ₹ 36.15B | ₹ 27.31B | ₹ 36.64B | ₹ 36.77B | ₹ 31.92B |
| Net Debt | ₹ 23.47B | ₹ 16.42B | ₹ 27.10B | ₹ 26.63B | ₹ 22.12B |
| Total Liabilities | ₹ 84.27B | ₹ 65.18B | ₹ 61.27B | ₹ 57.65B | ₹ 46.74B |
| Stockholders' Equity | ₹ 70.93B | ₹ 62.55B | ₹ 54.34B | ₹ 53.99B | ₹ 53.19B |
| Cash Flow | |||||
| Free Cash Flow | ₹ -4.36B | ₹ -435.00M | ₹ 736.00M | ₹ -1.54B | ₹ 2.38B |
| Operating Cash Flow | ₹ 10.13B | ₹ 10.72B | ₹ 9.71B | ₹ 6.61B | ₹ 8.38B |
| Investing Cash Flow | ₹ -12.85B | ₹ 4.88B | ₹ -6.08B | ₹ -5.44B | ₹ -3.80B |
| Financing Cash Flow | ₹ 3.33B | ₹ -14.53B | ₹ -4.33B | ₹ -1.57B | ₹ -325.99M |
Currency in INR

